Medical Devices
-
The MedTech Conference 2026
Cybersecurity in focus for top medtech lobby
ResMed CEO Mick Farrell, chair of AdvaMed’s board, said the group plans to come up with standards around privacy, cybersecurity and interoperability.
By Elise Reuter • Oct. 20, 2026 -
The MedTech Conference 2026
Medtech execs share secrets to building resilient supply chains
At AdvaMed’s The MedTech Conference, company executives said they’re bracing for disruption by investing in inventory, scenario planning and their relationships with chip suppliers.
By Susan Kelly • Oct. 20, 2026 -
Explore the Trendline➔
Sarah Silbiger via Getty Images
TrendlineTop 5 stories from MedTech Dive
From the effects of layoffs at the Food and Drug Administration and President Donald Trump’s tariff policies to the top medtech trends of 2026, here is a collection of top stories from MedTech Dive.
By MedTech Dive staff -
Medtronic wins CE mark for Vitalis portfolio of cardiac pacemakers
The CE mark clears Medtronic to sell conduction system pacing therapy devices in Europe.
By Nick Paul Taylor • Oct. 20, 2026 -
FDA clears Sequel’s insulin delivery system in Type 2 diabetes
With Twiist already available in Type 1 diabetes, Sequel has made the automated insulin delivery system available for the Type 2 population.
By Nick Paul Taylor • Oct. 19, 2026 -
Edwards recall of Sapien mitral delivery systems tied to 1 death
Edwards is asking customers to return some of the delivery systems used with its Sapien M3 devices after receiving three reports of balloons bursting when inflated during the procedure.
By Susan Kelly • Oct. 16, 2026 -
EndoQuest Robotics hires chief commercial officer
Jared Eben joins EndoQuest ahead of the anticipated launch of its flexible robotic surgery system.
By Nick Paul Taylor • Oct. 16, 2026 -
Zimmer and Think Surgical pen multi-year extension to robotic surgery deal
Zimmer distributes an exclusive version of Think’s wireless handheld miniature robotic system that works with its Persona knee system.
By Nick Paul Taylor • Oct. 15, 2026 -
Orthofix pays former executives $24M in damages
The payments were made after a California arbitrator found private text messages between Orthofix executives couldn’t be considered cause for firing.
By Maura Webber Sadovi • Oct. 14, 2026 -
Steris inks $2.1B Xodus buyout to expand consumables portfolio
The takeover adds high-growth, high-margin products to Steris’ portfolio, analysts said.
By Nick Paul Taylor • Oct. 13, 2026 -
Stryker enters soft tissue robotics with $400M investment in CMR Surgical
Stryker, which has been looking to get into the soft tissue robotics market for years, is now positioned to compete with new entrants Johnson & Johnson and Medtronic.
By Elise Reuter • Oct. 12, 2026 -
Philips updates instructions for ultrasound system linked to 4 deaths
A software issue can delay use of the Lumify diagnostic ultrasound system in environments without access to Wi-Fi or cellular signal.
By Nick Paul Taylor • Oct. 12, 2026 -
Medtech lobby seeks broader device eligibility for CMS’ proposed RAPID pathway
AdvaMed called for more breakthrough devices, including diagnostics, to be eligible for the pathway, and for set timelines for national coverage determinations.
By Elise Reuter • Oct. 9, 2026 -
Healthcare organizations are underprepared for quantum computing threats
Once scientists are able to develop practical quantum computers, the technology could quickly break the encryption methods protecting patient data. Experts say healthcare leaders should start preparing for that reality today.
By Jill Hughes • Oct. 9, 2026 -
MMI raises $125M to scale up in robotic microsurgery
The Symani surgical robot maker said the financing will help broaden adoption of the system in the U.S. and global markets and support a clinical trial for Alzheimer’s disease.
By Susan Kelly • Oct. 9, 2026 -
Henry Schein appoints Emmanuel Caprais as CFO
The CFO transition is part of a recent wave of leadership changes at Henry Schein, including a new CEO.
By Nick Paul Taylor • Oct. 9, 2026 -
Boston Scientific names Joseph Fitzgerald as chief operating officer
Fitzgerald will oversee three newly established reportable segments as Boston Scientific works to bounce back from guidance cuts.
By Nick Paul Taylor • Oct. 8, 2026 -
Medtronic names Felicia Kurz as cardiac ablation VP, GM
Kurz’s appointment comes as Medtronic enjoys strong growth in electrophysiology therapies thanks to demand for its pulsed field ablation devices.
By Susan Kelly • Oct. 7, 2026 -
Abbott gets FDA nod for updates to heart failure monitoring system
Patients can view their pulmonary artery pressure readings on their phone with the CardioMEMS updates, giving them a more active role in their care.
By Elise Reuter • Oct. 7, 2026 -
Apple ordered to pay Masimo $184M in interest on patent damages
A U.S. district court ruled that Apple owes prejudgment interest on the $634 million in damages it incurred for infringing Masimo’s pulse oximetry patent.
By Nick Paul Taylor • Oct. 7, 2026 -
Zenflow raises $52M, inks distribution deal with Cook Medical
Cook Medical has become Zenflow’s U.S. distributor in a urology device market targeted by Boston Scientific, Olympus and Teleflex.
By Nick Paul Taylor • Oct. 6, 2026 -
Stryker CEO Kevin Lobo to resign
Lobo will step down on Dec. 31 as CEO after more than 15 years at Stryker. Chief operating officer Spencer Stiles will lead the company.
By Elise Reuter • Oct. 6, 2026 -
BD strikes supply chain pact with Trump administration
BD plans to increase U.S. production of essential medical consumables in exchange for relief from future tariffs on its products.
By Susan Kelly • Oct. 6, 2026 -
Top medtech conferences in 2027
From AdvaMed’s meeting in San Francisco to a robotics conference in Rome, next year’s calendar is already filled with medtech events to attend.
By Ricky Zipp • Oct. 6, 2026 -
GE HealthCare to acquire Sofie Biosciences for $945M
Sofie Biosciences is expected to expand GE HealthCare’s footprint in the radiopharmaceutical industry, helping manufacture and distribute time-sensitive drugs used in PET imaging.
By Susan Kelly • Oct. 5, 2026 -
Q&A
After years-long turnaround, Convatec’s new CEO plans R&D push
Jonny Mason, who became CEO of the medtech firm a year ago following the death of Karim Bitar, said Convatec’s pace of launching new devices has accelerated for 2026 and 2027.
By Elise Reuter • Oct. 5, 2026